Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF

Human Gene Therapy

Volumn 11, Issue 12, 2000, Pages 1723-1729

  Bachoud Levi A C ^a,b   Deglon N ^c   Nguyen, J P ^a,b   Bloch, J ^c   Bourdet, C ^a,d   Winkel, L ^c   Remy P ^b,e   Goddard, M ^f   Lefaucheur, J P ^a,b   Brugieres P ^a,b   Baudic, S ^a   Cesaro, P ^a,b   Peschanski, Marc ^a   Aebischer, P ^c  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c University of Lausanne Medical Center   (Switzerland)

^d Hopital Albert Chenevier   (France)

^e DIF   (France)

^f CytoTherapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SPINY;

CILIARY NEUROTROPHIC FACTOR;

ANIMAL; ARTICLE; BRAIN VENTRICLE; CELL LINE; CLINICAL PROTOCOL; GENE THERAPY; GENE TRANSFER; GENETICS; HAMSTER; HUMAN; HUNTINGTON CHOREA; METABOLISM; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL; SECRETION;

ANIMALS; CELL LINE; CEREBRAL VENTRICLES; CILIARY NEUROTROPHIC FACTOR; CLINICAL PROTOCOLS; CLINICAL TRIALS, PHASE I; CRICETINAE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; HUNTINGTON DISEASE; PATIENT SELECTION;

EID: 0034632379     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050111377     Document Type: Article

References (59)

1. ADLER, R. (1993). Ciliary neurotrophic factor as an injury factor. Curr. Opin. Neurobiol. 3, 785-789.
2. AEBISCHER, P., WINN, S.R., and GALLETTI, P.M. (1988). Transplantation of neural tissue in polymer capsules. Brain Res. 448, 364-368.
3. AEBISCHER, P., BUCHSER, E., JOSEPH, J.M., FAVRE, J., DE TRIBOLET, N., LYSAGHT, M., RUDNICK, S., and GODDARD, M. (1994a). Transplantation in humans of encapsulated xenogenic cells without immunosuppression. Transplantation 58, 1275-1277.
4. AEBISCHER, P., GODDARD, M., SIGNORE, A.P., and TIMPSON, R.L. (1994b). Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp. Neurol. 126, 151-158.
5. AEBISCHER, P., SCHLUEP, M., DÉGLON, N., JOSEPH, J.-M., HIRT, L., HEYD, B., GODDARD, M., HAMMANG, J., ZURN, A.D., KATO, A., REGLI, F., and BAETGE, E.E. (1996a). Intrathecal delivery of CNTF using encapsulated genetically modified xenogeic cells in amyotrophic lateral sclerosis patients. Nature Med. 2, 696-699.
6. AEBISCHER, P., SCHLUEP, M., DÉGLON, N., JOSEPH, J.M., HIRT, L., HEYD, B., GODDARD, M., HAMMANG, J.P., ZURN, A.D., KATO, A.C., REGLI, F., and BAETGE, E.E. (1996b). Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis. Nature Med. 2, 696-699.
7. ANDERSON, K.D., PANAYOTATOS, N., CORCORAN, T.L., LINDSAY, R.M., and WIEGAN, S.J. (1996). Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proc. Natl. Acad. Sci. U.S.A. 93, 7346-7351.
8. BACHOUD-LEVI, A., BOURDET, C., BRUGIERES, P., NGUYEN, J.P., GRANDMOUGIN, T., HADDAD, B., JENY R., BARTOLOMEO, P., BOISSE, M.F., BARBA, G.D., DEGOS, J.D., ERGIS, A.M., LEFAUCHEUR, J.P., KISOVOSKI, F., PAILHOUS, E., REMY, P., PALFI, S., DEFER, G.L., CESARO, P., HANTRAYE, P., and PESCHANSKI, M. (2000). Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp. Neurol. 161, 194-202.
9. BATTIG, K., ROSVOLD, H.E., and MISHKIN, M. (1960). Comparison of the effects of frontal and caudate lesions on delayed response and alternation in monkeys. J. Comp. Physiol. Psychol. 53, 400-404.
10. BIRD, E.D., and COYLE, J.T. (1986). Huntington's disease. In Clinical Neurochemistry. Academic Press, London, pp. 1-57.
11. BLOTTNER, D., BRUGGEMAN, W., and UNSICKER, K. (1989). Ciliary neurotrophic factor supports traget-deprived preganglionic sympathetic spinal cord neurons. Neurosci. Lett. 105, 316-320.
12. BROOKS, D.J., and FRACKOWIAK, R.S.J. (1989). PET and movement disorders. J. Neurol. Neurosurg. Psychol. 68-77. [Special Supplement]
13. BROUILLET, E., CONDE, F., BEAL, M.F., and HANTRAYE, P. (1999). Replicating Huntington's disease phenotype in experimental animals. Prog. Neurobiol. 59, 427-486.
14. BUCHSER, E., GODDARD, M., HEYD, B., JOSEPH, J.M., FAVRE, J., DE TRIBOLET, N., LYSAGHT, M., and AEBISCHER, P. (1996). Immunoisolated xenogeneic chromaffin cell therapy for chronic pain: initial clinical experience. Anesthesiology 85, 1005-1012.
15. CEDARBAUM, J.M., CHAPMAN, C., CHARATAN, M., STAMBLER, N., ANDREWS, L., ZHAN, C., RADKA, S., MORRISEY, D., LAKINGS, D., BROOKS, B.R., et al. (1995). The pharmacokinetics of subcutaneously administered recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic 1 ateral sclerosis: Relation to parameters of the acute-phase response. Clin. Neuropharmacol. 18, 500-514.
16. CLATTERBUCK, R.E., PRICE, D.L., and KOLIATSOS, V.E. (1993). Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system. Proc. Natl. Acad. Sci. U.S.A. 90, 2222-2226.
17. DIVAC, J., ROSVOLD, H.E., and SZWARCHART, M.K. (1967). Behavioral effects of selective ablation of the caudate nucleus. J. Comp. Physiol. Psychol. 63, 184-190.
18. EIDELBERG, E., NGUYEN, L.H., POLICH, R., and WALDEN, J.G. (1989) Transsynaptic degeneration of motoneurones caudal to spinal cord lesions. Brain Res. Bull. 22, 39-45.
19. EMERICH, D.F., LINDNER, M.D., WINN, S.R., CHEN, E.Y., FRYDEL, B.R., and KORDOWER, J.H. (1996). Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J. Neurosci. 16, 5168-5181.
20. EMERICH, D.F., WINN, S.R., HANTRAYE, P.M., PESCHANSKI, M., CHEN, E.Y., CHU, Y., MCDERMOTT, P., BAETGE, E.E., and KORDOWER, J.H. (1997). Encapsulated CNTF-producing cells protect monkeys in a model of Huntington's disease. Nature (London) 386, 395-398.
21. HAGG, T., and VARON, S. (1993). Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 90, 6315-6319.
22. HENDERSON, J.T., SENIUK, N.A., RICHARDSON, P.M., GAULDIE, J., and RODER, J.C. (1994). Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J. Clin. Invest. 93, 2632-2638.
23. HUNTINGTON STUDY GROUP. (1996). Unified Huntington's Disease Rating Scale: Reliability and consistency. Mov. Disord. 11, 136-142.
24. HUNTINGTON'S GROUP. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosomes. Cell 72, 1-18.
25. JOSEPH, J.-M., GODDARD, M.B., MILLS, J., PADRUN, V., ZURN, A., ZIELINSKI, B., FAVRE, J., GARDAZ, J.P., MOSIMANN, F., SAGEN, J., CHRISTENSON, L., and AEBISCHER, P. (1994). Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: A preclinical study for the treatment of cancer pain. Cell Transpl. 3, 355-364.
26. KORDOWER, J.H., WINN, S.R., LIU, Y.T., MUFSON, E.J., SLADECK, J.R., JR, HAMMANG, J.P., BAETGE, E.E., and EMERICH, D.F. (1994). The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 91, 10898-10902.
27. KUHL, D.E., PHELPS, M.E., MARKHAM, C.H., METTER, E.J., RIEGE, W.H., and WINTER, J. (1982). Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann. Neurol. 12, 425-434.
28. KUWERT, T., LANGE, H.W., LANGEN, K.J., HERZOG, H., AULICH, A., and FEINENDEGEN, L.E. (1990). Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 113, 1405-1423.
29. LAVAIL, M.M., UNOKI, K., YASUMARA, D., MATTHES, D., YANCOPOULOS, G.D., and STEINBERG, R.H. (1992). Multiple growth factors, cytokines and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc. Natl. Acad. Sci. U.S.A. 89, 11249-11253.
30. LANGE, H., THORNER, G., HOPE, A., and SCHRODER, K.F. (1976). Morphometric studies of the neuropathological changes in choreatic diseases. J. Neural. Sci. 28, 401-425.
31. LIN, L.F., DRZISLAV, M., LILE, J.D., ARMES, L.G., BUTLER, E.T., VANNICE, J.L., and COLLINS, F. (1989). Purification cloning and expression of ciliary neurotrophic factor (CNTF). Science 246, 1023-1025.
32. LISOVOSKI, F., AKLI, S., PELTEKIAN, E., VIGNE, E., HAASE, G., PERRICAUDET, M., DREYFUS, P.A., KAHN, A., and PESCHANSKI, M. (1997). Phenotypic alteration of astrocytes induced by CNTF in the intact adult brain, as revealed by adenovirus-mediated gene transfer. J. Neurosci. 17, 7228-7236.
33. LUNDERVOLD, A.J., and REINVANG, I. (1994). Neuropsychological findings and depressive symptoms in patients with Huntington's disease. Scand. J. Psychol. 32, 275-283.
34. MARTY, S., and PESCHANSKI, M. (1995). Effects of target deprivation on the morphology and survival of adult dorsal column nuclei neurons. J. Comp. Neurol. 356, 523-536.
35. MAZZIOTTA, J.C., PHELPS, M.E., PAHL, J.J., HUANG, S.C., BAXTER, L.R., RIEGE, W.H., HOFFMAN, J.M., KUHL, D.E., LANTO, A.B., WAPENSKI, J.A., and MARKHAM, C.H. (1987). Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N. Engl. J. Med. 316, 357-362.
36. MCHUGH, P.R., and FOLSTEFN, M.F. (1975). Psychiatric syndromes of Huntington's chorea: A clinical and phenomenologic study. In D.F. Benson and D. Blumer (eds.). Psychiatric Aspects of Neurologic Disease. Grune & Stratton, New York, pp. 267-285.
37. MITSUMOTO, H., IKEDA, K., HOLMLUND, T., GREENE, T., CEDARBAUM, J.M., WONG, V., and LINDSAY, R.M. (1994). The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann. Neurol. 36, 142-148.
38. MITTOUX, V., OUARY, S., MONVILLE, C., LISOVOSKI, F., CONDÉ, F., BROUILLET, E., TREMBLEAU, A., PESCHANSKI M., and HANTRAYE P. (1999). Adenoviral gene therapy in a rodent model of Huntington's disease. Neurosci. Abst. 25, 1010.
39. MITTOUX, V., JOSEPH, J.M., CONDÉ, F., et al. (2000). Restoration of cognitive and motor function with ciliary neurotrophic factor in a primate model of Huntington's disease. Hum. Gene Ther. 11, 1177-1187.
40. OPPENHEIM, R.W., PREVETTE, D., QIN-WEI, Y., COLLINS, F., and MACDONALD, J. (1991). Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 251, 1616-1618.
41. OYANAGI, K., TAKEDA, S., TAKAHASHI, H., OHAMA, E., and IKUTA, F. (1989). A quantitative investigation of the substantia nigra in Huntington's disease. Ann. Neurol. 26, 13-19.
42. PALFI, S., FERRANTE, R.J., BROUILLET, E., BEAL, M.F., DOLAN, R., GUYOT, M.C., PESCHANSKI, M., and HANTRAYE, P. (1996). Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J. Neurosci. 16, 3019-3025.
43. PESCHANSKI, M., CESARO, P., and HANTRAYE, P. (1995). Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 68:273-285.
44. PLAUTZ, G., NABEL, E.G., and NABEL, G.J. (1991). Selective elimination of recombinant genes in vivo with a suicide retroviral vector. N. Biol. 3, 709-715.
45. QUINN, Q., BROWN, R., CRAUFURD, D., GOLDMAN, S., HODGES, J., KIEBURTZ, K., MACMILLAN, J., and ROOS, R. (1996). Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Movement Dis. 11, 143-150.
46. RICHARDSON, P.M. (1994). Ciliary neurotrophic factor: A review. Pharmacol. Ther. 63, 187-198.
47. SAGOT, Y., TAN, S.A., BAETGE, E., SCHMALBRUCH, H., KATO, A.C., and AEBISCHER, P. (1995). Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur. J. Neurosci. 7, 1313-1322.
48. SAUDOU, F., FINKBEINER, S., DEVYS, D., and GREENBERG, M.E. (1998). Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
49. SENDTNER, M., KREUTZBERG, G.W., and THOENEN, H. (1990). (London) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature (London) 345, 440-441.
50. SENDTNER, M., SCHMALBRUCH, H., STÖKLI, K.A., CAROLL, P., KREUTZBERG, G.W., and THOENEN, H. (1992). Ciliary neurotrophic factor prevents the degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature (London) 358, 502.
51. SHAPIRO, L., ZHANG, X.-X., RUPP, R.G., WOLFF, S.M., and DINARELLO, C.A. (1993). Ciliary neurotrophic factor is an endogenous pyrogen. Proc. Natl. Acad. Sci. U.S.A. 90, 8614-8618.
52. SOTREL, A., PASKEVICH, P.A., KIELY, D.K., BIRD, E.D., WILLIAMS, R.S., and MYERS, R.H. (1991). Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 41, 1117-1123.
53. STÖCKLI, K.A., LOTTSPEICH, F., SENDTNER, M., MASIAKOWSKI, P., CARROLL, P., GOTZ, R., LINDHOLM, D., and THOENEN, H. (1989). Molecular cloning expression and regional distribution of rat ciliary neurotrophic factor. Nature (London) 342, 920-923.
54. STÖCKLI, K.A., LILLIEN, L.E., NAHER-NOÉ, M., et al. (1991). Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain. J. Cell. Biol. 115, 447-459.
55. TSENG, J.L., BAETGE, E.E., ZURN, A.D., and AEBISCHER, P. (1997). GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J. Neurosci. 17, 325-333.
56. VONSATTEL, J.P., MYERS, R.H., STEVENS, T.J., FERRANTE, R.J., BIRD, E.D., and RICHARDSON, E.P., JR. (1985). Neuropathological classification of Huntington's disease. J. Neuropath. Exp. Neurol. 44, 559-577.
57. WATERS, C.M., PECK, R., ROSSOR, M., REYNOLDS, G.P., and HUNT, S.P. (1988). Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Neuroscience 25, 419-438.
58. WEINBERGER, D.R., BERMAN, K.F., IADAROLA, M., DRIESEN, N., and ZEC, R.F. (1988). Prefrontal cortical blood flow and cognitive function in Huntington's disease. J. Neuro. Neurosurg. Psy. 51, 94-104.
59. WELLINGTON, C.L., and HAYDEN, M.R. (2000). Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches. Clin. Genet. 57, 1-10.